Collegium Pharmaceutical Inc (COLL) — Cash Flow Reinvestment Rate
Collegium Pharmaceutical Inc (COLL) has a Cash Flow Reinvestment Rate of 0.40x as of September 2025, reinvesting $31.06 Million (capex $188.00K plus investments $-30.87 Million) from operating cash flow of $78.44 Million. Explore capital reinvestment ratio of Collegium Pharmaceutical Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Collegium Pharmaceutical Inc Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Collegium Pharmaceutical Inc across 7 annual periods. Also explore Collegium Pharmaceutical Inc (COLL) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Collegium Pharmaceutical Inc (2018–2024)
Year-by-year capital reinvestment analysis for Collegium Pharmaceutical Inc. For live market cap and broader valuation context, see market value of Collegium Pharmaceutical Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | $289.41 Million | $204.98 Million | $1.65 Million | ▲ +723.3% |
| 2023 | 0.17x | $47.12 Million | $274.75 Million | $461.00K | ▼ -96.3% |
| 2022 | 4.63x | $575.31 Million | $124.23 Million | $1.62 Million | ▲ +12234.8% |
| 2021 | 0.04x | $3.89 Million | $103.56 Million | $1.94 Million | ▼ -99.5% |
| 2020 | 7.96x | $747.54 Million | $93.94 Million | $373.77 Million | ▲ +1617.0% |
| 2019 | 0.46x | $12.88 Million | $27.78 Million | $6.44 Million | ▲ +61.2% |
| 2018 | 0.29x | $48.71 Million | $169.39 Million | $24.35 Million | — |